🇺🇸 FDA
Patent

US 11833172

Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration

granted A61KA61K31/728A61K33/24

Quick answer

US patent 11833172 (Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration) held by The Regents of the University of Colorado expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/728, A61K33/24, A61K47/549, A61K47/55